Bortezomib is used to treat people with multiple myeloma (a type of cancer of the bone marrow). Bortezomib is also used to treat people with mantle cell lymphoma (a fast-growing cancer that begins in the cells of the immune system). Bortezomib is in a class of medications called antineoplastic agents. It works by killing cancer cells.
CAT Number | CHR-9122018-1096 |
---|---|
CAS Number | 63-91-2 |
Mol.F | C9H11NO2 |
Mol.Wt | 165.189 g/mol |
Inventory status | In-Stock |
CAT Number | CHR-9122018-1806 |
---|---|
CAS Number | 114457-94-2 |
Mol.F | C14H13N3O3 |
Mol.Wt | 271.271 g/mol |
Inventory status | In-Stock |